NAD+ Protocol: Experimental Design, Not Clinical

The phrase NAD+ protocol returns three kinds of document, and they have almost nothing in common beyond the word. One is a research instrument. One is a commercial operating procedure. One is a post. Deciding which you are holding settles most of what you can conclude from it.

This compound presents a version of the problem that no other entry on this site does, because for NAD+ the properly written research protocols genuinely exist. They are just not protocols for the thing being sold.

NAD+ protocol: which of three documents is meant

A registered trial protocol is a document written before enrolment. It names the intervention and its formulation, specifies who may be enrolled and who may not, fixes the primary outcome and how it will be measured, states the statistical analysis in advance, defines how adverse events are captured and graded, and commits the investigators to those choices before any data exist.

A clinic infusion procedure is a service description. It records what staff do: how the bag is prepared, over what period it runs, what is monitored while it does, and what happens if a client reacts. That is legitimate operational documentation and it is not designed to produce knowledge.

A circulating schedule is a sequence of quantities and intervals with no origin, no outcome definition and no comparison. It borrows the authority of the first document while containing the content of neither.

The registered protocols exist and specify another intervention

Search a trial registry for this topic and records appear in quantity. Opening them changes the picture: the intervention field in the great majority names an oral precursor, most often nicotinamide riboside or nicotinamide mononucleotide, taken by mouth as a capsule.

Those are properly specified documents. Someone wrote down in advance what would be given, to whom, for how long, and what would count as success. The protocol discipline is present and it is applied to a molecule the reader is not buying, delivered by a route the reader is not using.

This is why quoting a number of registered studies without naming the intervention is the characteristic error on this compound. The count is real. What it counts is precursor work.

A clinic operating procedure is a service description

Infusion providers often publish something that looks protocol shaped, and it is worth reading for what it does contain. Preparation steps, infusion duration, observation during administration and stopping rules if a client becomes unwell are all reasonable things to write down.

None of them constitutes a research design, because nothing in the document is arranged to answer a question. There is no comparison group, no outcome fixed before the client arrived, no blinding, and no plan for analysing anything. A document that describes how a service is delivered cannot show that the service works, regardless of how carefully it is written or how consistently it is followed.

Element by element, across the three documents

Read down the columns rather than across the rows. The first column is a knowledge producing instrument aimed at a precursor. The second is a competent service record. The third has the vocabulary of the first and the informational content of nothing.

Why prespecification is the load bearing element

Of everything in that table, one row does more work than the rest. Fixing the outcome before the data exist is what prevents a result from being chosen after the fact.

Without it, an investigator with several measurements can report whichever moved. That is not usually dishonest; it is how human attention works when a study produces a dozen numbers and one of them looks interesting. Prespecification removes the option, which is precisely the point of writing it down first.

An infusion service collects no prespecified outcome, so the client’s own assessment becomes the outcome by default, selected after the experience and coloured by everything the experience contained: the cost, the hour spent sitting still, the attention of staff and the expectation formed before arrival.

Who the document is written to protect

A research protocol is often read as a recipe, which understates it. Most of its length exists to protect the people enrolled, and that portion is invisible in any version that circulates as a schedule.

Before a trial opens, an ethics committee reviews the document and can require changes or refuse it. Participants receive a consent process describing what is known and unknown about the intervention. Someone is responsible for capturing adverse events, grading them and reporting them upward on a defined timetable. Studies with meaningful risk have a monitoring committee that can see accumulating safety data and stop the trial. Withdrawal criteria state in advance what would remove a participant.

An infusion delivered outside that framework carries none of it, and a schedule copied from a post carries less still. The absence is easy to overlook because none of these elements produces a visible output when nothing goes wrong. They are the parts of the document that only reveal their function in the cases where they are needed.

Transplanting a protocol changes what it means

Even a genuine precursor trial protocol does not become usable by rewriting the intervention line. The rest of the document was built around the intervention it names. Eligibility criteria were chosen for a compound taken by mouth. Monitoring was designed for the adverse events that route can produce. The outcome and its timing were set by the pharmacokinetics of a swallowed precursor.

Change the molecule and the route, and every one of those choices is now unjustified. What remains is a formatting template. A protocol is a set of commitments about a specific intervention, and it does not survive substitution of its subject.

The same reasoning applies to the outcome measure, which is the element most often carried across without inspection. An oral precursor trial that measured blood NAD+ concentrations at a defined interval chose that interval because of how quickly a swallowed capsule is absorbed and converted. Measuring the same marker at the same interval after an infusion answers a different pharmacokinetic question, and a result read off that schedule would be uninterpretable rather than merely imprecise.

What is left once the infrastructure is removed

Strip the prespecification, the comparison group, the blinding, the adverse event system and the oversight from a protocol and something still remains: a sequence of actions. That residue is what circulates, and its persuasive power comes from looking like the original.

The residue can be followed exactly and produce no information. A person can administer the stated quantity at the stated interval with complete fidelity and end the period knowing only how they felt, which is what they would have known without the schedule. Fidelity to a procedure is a property of the person following it. Whether the procedure can generate an answer is a property of how it was designed, and the two are independent.